Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bosentan for Severe Mitral Valve Dysfunction (BOSMIVAR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by General Hospital of Chalkida.
Recruitment status was  Recruiting
Information provided by:
General Hospital of Chalkida Identifier:
First received: January 4, 2011
Last updated: January 27, 2011
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2011
  Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)